Living with Irresolute Cell Lines in an Automated World

Journal of Laboratory Automation

Volumn 13, Issue 3, 2008, Pages 159-167

  Hogan, Christopher ^a   Simons, Sarah ^a   Zhang, Haiyan ^a   Burdick, Debra ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

automated; automation; capacity; cell based; cell culture; cell line; cell model; confluency; drug discovery; efficiency; mammalian; scale up

Indexed keywords

BIOTECHNOLOGY; CELL CULTURE; CELLS; DRUG THERAPY; GENETIC ENGINEERING;

AUTOMATED CELL CULTURE; DRUG DISCOVERY; GENETIC INCLINATION;

AUTOMATION;

ARTICLE; CELL CULTURE; CELL CULTURE EQUIPMENT; CELL GROWTH; CELL KINETICS; CELL SURVIVAL; CONTROLLED STUDY; DOWNSTREAM PROCESSING; EUKARYOTIC CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; MAMMAL CELL; PHENOTYPE; ROBOTICS;

EID: 42949128515     PISSN: 22110682     EISSN: 15402452     Source Type: Journal    
DOI: 10.1016/j.jala.2008.01.004     Document Type: Article

References (33)

1. Genové G. Glick B. Alison L. Barth A. Brighter reporter genes from multimerized fluorescent proteins. BioTechniques 2005, 39(6), 814–822.
2. Nottebaum L. Ford I. Santos M. Malany S. Foster A. Lechner S. A novel cell-based assay for G-protein-coupled receptor-mediated cyclic adenosine monophosphate response element binding protein phosphorylation. J. Biomol. Screen. 2006, 11(4), 351–358.
3. Hanson K. D. Sedevy J. M. Analysis of biological selections for high efficiency gene targeting. Mol. Cell Biol. 1995, 15, 45–51.
4. Archer R. History, evolution, and trends in compound management for high throughput screening. Assay Drug Dev. Technol. 2004, 2(6), 675–681.
5. Sanders G. H. W. Manz A. The incredibly shrinking laboratory reactions, seperations and detections. J. Assoc. Lab. Autom. 2000, 5(5), 40–45.
6. Eggert U. S. Mitchison T. J. Small molecule screening by imaging. Curr. Opin. Chem. Biol. 2006, 10(3), 323–327.
7. Shav-Tal Y. Singer R. H. Darzacq X. Imaging gene expression in living cells. Nat. Rev. Mol. Cell Biol. 2004, 855–862.
8. Dhiman A. S. Cell based assay technologies—the road to success? Frost & Sullivan; 2004 October 22.
9. Toffler A. Future Shock ISBN-10 0553277375 New York, NY: Bantam (Randomhouse); 1984.
10. Masters J. HeLa cells 50 years on: The good, the bad and the ugly. Nat. Rev. Cancer 2002, 315–319.
11. Dawkins R. River Out of Eden ISBN-10 0465069908 HarperCollins Publishers: New York, NY; 1996.
12. Tao H. Santa Ana D. Guia A. Huang M. Ligutti J. Walker G. Sithiphong K. Chan F. Guoliang T. Zoya Z. Saya S. Phimmachak R. Sie C. Yuan J. Wu L. Xu J. Ghetti A. Automated tight seal electrophysiology for assessing the potential hERG liability of pharmaceutical compounds. Assay Drug Dev. Technol. 2004, 2(5), 497–506.
13. Vierck J. L. Dodson M. V. Interpretation of cell culture phenomena. Methods Cell Sci. 2000, 22(1), 79–81.
14. Zhang J. H. Chung T. D. Oldenburg K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999, 4(2), 67–73.
15. Cawkill D. Eaglestone S. Evolution of cell-based reagent provision. Drug Discov. Today 2007, 12(19–20), 820–825.
16. Ng E. S. Davis R. P. Azzola L. Stanley E. G. Elefanty A. G. Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood 2005, 107, 2180–2183.
17. Amit M. Itskovitz-Eldor J. Derivation and spontaneous differentiation of human embryonic stem cells. J. Anat. 2002, 200(3), 225–232.
18. Wang L. Adamo M. L. Cell density influences insulin-like growth factor I gene expression in a cell type-specific manner endocrinology 2000, 141(7), 2481–2489.
19. Malthus R. An Essay on the Principle of Population. [J. Johnson]. 1st edition. London; 1798. Reprinted in Penguin Classics, Penguin Book Ltd.: London, England; 1985.
20. Maynard T. Wakamatsu Y. Weston J. Cell interactions within nascent neural crest cell populations transiently promote death of neurogenic precursors. Development 2000, 127, 4561–4572.
21. Morrison S. Perez S. Zhou Q. Verdi J. Hicks C. Weinmaster G. Anderson D. Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell 2000, 101, 499–510.
22. Hendriks J. Riesle J. Vanblitterswijk C. Effect of stratified culture compared to confluent culture in monolayer on proliferation and differentiation of human articular chondrocytes. Tissue Eng. 2006, 12(9), 2397–2405.
23. Cukierman E. Pankov R. Yamada K. Cell interactions with three-dimensional matrices. Curr. Opin. Cell Biol. 2002, 14(5), 633–639.
24. Chen J. Lake M. Sabet R. Niforatos W. Pratt S. Cassar S. Xu J. Gopalakrishnan S. Pereda-Lopez A. Gopalakrishnan M. Holzman T. Moreland B. Walter K. Faltynek C. Warrior U. Scott V. Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonists. J. Biomol. Screen. 2007, 12(1), 61–69.
25. Baust J. M. Van Buskirk R. G. Baust J. G. Gene activation of the apoptotic caspase cascade following cryogenic storage. Cell Preservation Technology 2002, 1(1), 63–80.
26. Hallare V. Kohler H. R. Triebskorn R. Development toxicity and stress responses in zebrafish embryos after exposure to diclofenac and its solvent. Chemoshpere 2004, 56(7), 659–666.
27. Scheinkönig C. Kappicht S. Kolb H. J. Schleuning M. Adoption of long term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells. Bone Marrow Transplant. 2004, 34(6), 531–536.
28. Depraetere S. Vanhaesebroeck B. Fiers W. Willems J. Joniau M. Polar agents with differentiation inducing capacity potentiate tumor necrosis factor-mediated cytotoxicity in human myeloid cells. J. Leukoc. Biol. 1995, 57(1), 141–151.
29. Fareh J. Martel R. Kermani P. Leclerc G. Cellular effects of beta-particle delivery on vascular smooth muscle cells and endothelial cells. Circulation 1999, 99, 1477–1484.
30. Ponchio L. Duma L. Oliveiro B. Gibelli N. Pedrazzoli P. Robustelli G. Mitomycin C as an alternative to irradiation to inhibit the feeder layer growth in long term assays. Cytotherapy 2000, 2, 281–286.
31. Correia J. J. Lobert S. Physiochemical aspects of tubulin-interacting antimitotic drugs. Curr. Pharm. Des. 2001, 7(13), 1213–1228.
32. Kang Y. Lee K. Ryu H. Lee J. Lim S. Park S. Paik S. Yoon D. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells. Cancer Lett. 2006, 237(1), 33–44.
33. Blagosklonny M. V. Chuman Y. Bergan R. C. Fojo T. Mitogenactivated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells. Leukemia 1999, 1313(7), 1028–1036.